Fundraising Fox
/Companies
Sign in

CellFE

Atlanta, US · Founded 2018 · 20 employees on LinkedIn · 6 known investors

Find your way into CellFE

888 people in our graph share verified history with the CellFE team — schools, employers, funds. One of them is your warm intro.

Daniella Kranjacunlockedknows Todd Sulchek · together at CellFE (overlapped)
×3knows the team · via CellFE
×8knows the team · via Georgia Institute of Technology

CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams. The company's platform enables more efficient and accessible production of cell therapies for treatment applications.

BiotechDeep TechHardwareMedical Devices

Founders & leadership

AZAlla Zamarayeva, PhD
Alla Zamarayeva, PhDCEO & Co-founder
TS
Todd Sulchek, PhDCSO & Co-founder
AA
Alex Alexeev, PhDCo-founder
AZAlla Zamarayeva
Alla ZamarayevaCEO & Co-founder
TSTodd Sulchek
Todd SulchekCSO & Co-founderTodd Sulchek is a Professor of Mechanical Engineering at Georgia Tech with faculty appointments in Bioengineering and Biomedical Engineering. He previously worked as a Postdoctoral Researcher and Staff Scientist at Lawrence Livermore National Laboratory and earned his PhD in Applied Physics from Stanford University.
AAAlex Alexeev
Alex AlexeevCo-founder

Investors · 6

Cota Capitallisted by Cota CapitalSan Francisco

How we know: a partner's Signal profile · funding news · cellfebiotech.com · Not right? Tell us

GreatPoint Ventureslisted by GreatPoint VenturesSan Francisco · $250K – $20M

How we know: GreatPoint Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

M Ventureslisted by M VenturesLos Angeles · $10.8M

How we know: the VCSheet dataset · Not right? Tell us

Embark VenturesreportedLos Angeles

How we know: funding news · cellfebiotech.com · the VCSheet dataset · Not right? Tell us

Khosla VenturesreportedMenlo Park · $5K – $50M

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$25.6M disclosed across 2 rounds · 2020–2023

Source: company announcements and press reports — follow each round's link for the claim.

In the news

CellFE: Revolutionizing Cell Therapy Manufacturing with Microfluidic Gene Delivery Technology -biotechmetro.com · Apr 2025Endpoints News: CellFE raises $22M Series A to advance a new cell therapy manufacturing idea | CellFEcellfebiotech.com · Sep 2023CellFE Raises $22M in Series A Financingfinsmes.com · Sep 2023CellFE secures $22 million in Series A financing to advance microfluidics-based cellular engineering platform | CellFEcellfebiotech.com · Sep 2023CellFE Raises $3.6M in Seed Funding - FinSMEsfinsmes.com · Jan 2020CellFE Closes Series Seed Funding Round | CellFEcellfebiotech.com · Jan 2020

Frequently asked questions

What does CellFE do?
CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams. The company's platform enables more efficient and accessible production of cell therapies for treatment applications.
Who founded CellFE?
CellFE was founded by Alla Zamarayeva, PhD, Todd Sulchek, PhD, Alex Alexeev, PhD, Alla Zamarayeva, Todd Sulchek, Alex Alexeev in 2018.
Who are CellFE's investors?
CellFE's investors include Dynamk Capital, Cota Capital, GreatPoint Ventures, M Ventures, Embark Ventures, Khosla Ventures.
How much funding has CellFE raised?
CellFE has disclosed $25.6M raised across 2 rounds.
Where is CellFE headquartered?
CellFE is headquartered in Atlanta, US.